Teva announces FDA approval of Austedo® (deutetrabenazine) tablets for the treatment of tardive dyskinesia in adults

5th September 2017 Uncategorised 0

Teva Pharmaceutical Industries

More: Teva announces FDA approval of Austedo® (deutetrabenazine) tablets for the treatment of tardive dyskinesia in adults
Source: MDlinx